The Hsa-miR-27a rs895819 (A>G) polymorphism and cancer susceptibility

Gene

Volumn 521, Issue 1, 2013, Pages 87-90

  Wang, Zexing ^a   Lai, Jing ^b   Wang, Yanru ^b   Nie, Weiwei ^b   Guan, Xiaoxiang ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Hsa miR 27a; Polymorphism; Risk

Indexed keywords

MICRORNA; MICRORNA 27A; UNCLASSIFIED DRUG;

ARTICLE; BIBLIOGRAPHIC DATABASE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CORRELATION ANALYSIS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL;

CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MICRORNAS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84876740608     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.02.042     Document Type: Article

References (33)

1. Babashah S., Soleimani M. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur. J. Cancer 2011, 47:1127-1137.
2. Belair C., Darfeuille F., Staedel C. Helicobacter pylori and gastric cancer: possible role of microRNAs in this intimate relationship. Clin. Microbiol. Infect. 2009, 15:806-812.
3. Berry K.J., Johnston J.E., Mielke P.W. An alternative measure of effect size for Cochran's Q test for related proportions. Percept. Mot. Ski. 2007, 104:1236-1242.
4. Catucci I., et al. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res. Treat. 2012, 133:805-807.
5. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
6. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
7. Foulkes W.D. Inherited susceptibility to common cancers. N. Engl. J. Med. 2008, 359:2143-2153.
8. Guttilla I.K., White B.A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J. Biol. Chem. 2009, 284:23204-23216.
9. He B., et al. The Association between four genetic variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One 2012, 7:e49032.
10. Hezova R., et al. Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer. World J. Gastroenterol. 2012, 18:2827.
11. Iorio M.V., Croce C.M. microRNA involvement in human cancer. Carcinogenesis 2012, 33:1126-1133.
12. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
13. Kong Y.W., Ferland-McCollough D., Jackson T.J., Bushell M. microRNAs in cancer management. Lancet Oncol. 2012, 13:e249-e258.
14. Kontorovich T., Levy A., Korostishevsky M., Nir U., Friedman E. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women. Int. J. Cancer 2010, 127:589-597.
15. Li Z., et al. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol. Oncol. 2010, 119:125-130.
16. Liu T., Tang H., Lang Y., Liu M., Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 2009, 273:233-242.
17. Ma Y., Yu S., Zhao W., Lu Z., Chen J. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. Cancer Lett. 2010, 298:150-158.
18. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
19. Mertens-Talcott S.U., Chintharlapalli S., Li X., Safe S. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Res. 2007, 67:11001-11011.
20. Pritchard C.C., Cheng H.H., Tewari M. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 2012, 13:358-369.
21. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 2010, 10:389-402.
22. Shi D., et al. A genetic variant in pre-miR-27a is associated with a reduced renal cell cancer risk in a Chinese population. PLoS One 2012, 7:e46566.
23. Sun Q., et al. Hsa-mir-27a genetic variant contributes to gastric cancer susceptibility through affecting miR-27a and target gene expression. Cancer Sci. 2010, 101:2241-2247.
24. Wang Q., et al. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene 2011, 30:3875-3886.
25. Wang F., Sun G., Zou Y., Li Y., Hao L., Pan F. Association of microRNA-499 rs3746444 polymorphism with cancer risk: evidence from 7188 cases and 8548 controls. PLoS One 2012, 7:e45042.
26. Xu W., et al. Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One 2011, 6:e20471.
27. Yang R., et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res. 2010, 121:693-702.
28. Zeng Y., Yi R., Cullen B.R. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J. 2004, 24:138-148.
29. Zhang H., et al. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig. Dis. Sci. 2010, 55:2545-2551.
30. Zhang Z., Liu S., Shi R., Zhao G. miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition. Cancer Genet. 2011, 204:486-491.
31. Zhang M., et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur. J. Cancer Care 2012, 21:274-280.
32. Zhou Y., et al. Association analysis of genetic variants in microRNA networks and gastric cancer risk in a Chinese Han population. J. Cancer Res. Clin. Oncol. 2012, 138:939-945.
33. Zhu H., et al. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem. Pharmacol. 2008, 76:582-588.